Company Filing History:
2 out of 230 
2 out of 1,745 
Years Active: 2017-2020
Title: Karim Harhouri: Innovator in Angiogenesis Modulation
Introduction
Karim Harhouri is a notable inventor based in Marseilles, France. He has made significant contributions to the field of human therapy through his innovative work on soluble CD146 proteins. With a total of 2 patents, his research focuses on modulating angiogenesis, which is crucial for various therapeutic applications.
Latest Patents
One of Harhouri's latest patents is titled "Human soluble CD146, preparation and uses thereof." This invention relates to compositions and methods for modulating angiogenesis in vivo, ex vivo, or in vitro. More specifically, it involves a soluble CD146 protein that can be utilized in human therapy, along with corresponding antibodies. The described forms of CD146 can mobilize both mature and immature endothelial cells, enhancing their role in angiogenesis. The invention also encompasses pharmaceutical or diagnostic compositions, including kits, and methods for therapy or diagnosis using these compounds.
Career Highlights
Throughout his career, Karim Harhouri has worked with esteemed institutions such as Université d'Aix-Marseille and the Institut National de la Santé et de la Recherche Médicale. His research has significantly advanced the understanding of angiogenesis and its therapeutic implications.
Collaborations
Harhouri has collaborated with notable colleagues, including Marcel Blot-Chabaud and Nathalie Bardin. These partnerships have contributed to the success of his research endeavors.
Conclusion
Karim Harhouri's innovative work in the field of angiogenesis modulation highlights his importance as an inventor. His contributions are paving the way for advancements in human therapy and diagnostics.